Activating Media for Salt Reduction

Status Completed

Clinical Trial Summary

Mass media plays more and more important role in health education, especially in some chronic diseases which related closely with the behavior and habits. Past experience tells us that with the help of related health education in mass media such as newspaper articles, advertisements and videos on television, peoples can change their behaviors and habits in a short period of time. But when these educational information were stopped, peoples usually return to their original habits. Besides the national policy of the country how to improve the long-term health education in the mass media should be considered.This study hopes to seek an effective method to keep the mass media long-term focus on health education.

Clinical Trial Description

In this study, reporters just like researchers were in charge of the low-sodium salt intervention. Reporters are responsible for recommended objects and measure their blood pressure personally. By observing personally the change of blood pressure pre and post low-sodium salt intervention, reporters will increase their confidence and come to the conclusion that the low salt diet is an economical way to reduce blood pressure. Those reporters would share their experiment with other people including their colleagues, Hopefully, those reporters that took part in the trial would consciously keep a sustained focus to this topic, thereby retaining a long-time education in mass media.There were two interventions. One is low-sodium salt intervention and the other is informational intervention. Low-sodium salt intervention was carried out on those family members recommended by reporters, and informational intervention. Low-sodium salt intervention was only on the reporters. The evaluation criteria of low-sodium salt intervention is the blood pressure value, and the evaluation criteria of informational intervention are the numbers of related articles in certain newspaper and the awareness of related knowledges in local population. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03074851
Study type	Interventional
Source	The George Institute for Global Health, China
Contact
Status	Completed
Phase	N/A
Start date	December 2012
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02223793` - Vascular Lifestyle-Intervention and Screening in Pharmacy	N/A
Completed	`NCT02299388` - To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study	Phase 4
Completed	`NCT02655029` - Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination	N/A
Active, not recruiting	`NCT01500590` - Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria	Phase 4
Not yet recruiting	`NCT05548881` - Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype Study
Completed	`NCT01897155` - Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain.	Phase 4
Recruiting	`NCT02128386` - Medication Adherence and "True" Resistance in Patients With Resistant Hypertension	N/A
Completed	`NCT01501916` - Effect of Vitamin D3 on Cardiovascular Risk Factors	N/A
Recruiting	`NCT02530853` - Acupuncture as a Complementary Treatment for Hypertension (ACT-HAS)	N/A
Active, not recruiting	`NCT02697708` - Retention of Potassium From Potatoes and Potassium Gluconate, and the Effect on Blood Pressure.	Phase 1/Phase 2
Withdrawn	`NCT03897790` - Evaluation of Transcranial Doppler Vasoconstrictor Vasoreactivity During General Anesthesia in Hypertensive Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.